Pharmaceutical
Lavaa's suite of advanced digital tools offer responsible research-led pharmaceutical and biotech companies the opportunity to offer cutting edge treatments to many who would otherwise be trapped with life-limiting conditions.
Identifying eligible patients
for clinical trial recruitment for rare disease treatments
Our platform clears the path to an efficient, compliant and secure means to recruit patients with rare and hard to diagnose conditions into Phase-3 clinical trials.
Lavaa's proprietary scoring systems that predict a patient's risk profile with respect to unique chronic long-term conditions can be applied in an intelligent way to identify potential eligible trial participants as part of patient access programs or late stage research.
Patients living in a progressive state of disease can consent to take part in trials once their eligibility is confirmed, offering them possible alternative treatments.
Development
in Partnership
Clinical researchers working in partnership with pharmaceutical firm partners can build engines within our Interactive Development Environment to create the means to accelerate research, delivering results for peer-review and ultimately, onto the market more quickly than would otherwise be the case.
As a Software-as-a-Service based digital platform, Lavaa enables this type of collaborative working across borders.
Learn More